Acadia Healthcare Q3 2022: revenue up 13.5%, adj. EPS $0.86, narrows FY guidance

Acadia Healthcare Company, Inc.

2022-Q3 EPS reported $2.31 revenue$1,935,104,000

Revenue $666.7M (+13.5% YoY); same-facility revenue +10.2% on 6.9% revenue/patient day and 3.1% patient day growth.
Net income $71.1M ($0.78 diluted EPS); adjusted EPS $0.86 (incl. $0.06 from PRF); ex-PRF adj. EPS $0.80.
Adjusted EBITDA $162.8M (incl. $7.7M PRF); ex-PRF $155.1M; net leverage ratio ~2.1x; $515M revolver available.
Narrowed 2022 guidance: revenue $2.58-2.60B; Adj. EBITDA (excl. PRF) $595-605M; Adj. EPS $3.00-3.10 (excl. PRF).
Added 132 beds in Q3, opened 60-bed children's hospital in Chicago and 2 CTCs; on track for ~300 beds in 2022.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

Acadia Healthcare Company, Inc. reported the third quarter ended September 30, 2022 results: revenue $666.7 million, net income $71.1 million, EPS $0.78 per diluted share.

Period: the third quarter ended September 30, 2022
Revenue: $666.7 million
Net income: $71.1 million
EPS: $0.78 per diluted share
Result: reported results

Exact text from the filing

The Company reported revenue of $666.7 million for the third quarter of 2022, compared with $587.6 million for the third quarter of 2021. Adjusted EBITDA was $162.8 million for the third quarter of 2022, compared with $141.9 million for the same period last year. Excluding income from the PRF, Adjusted EBITDA was $155.1 million for the third quarter of 2022. The Company recorded income from the PRF of $7.7 million in the third quarter of 2022. The Company will continue to review the remaining $14.2 million of American Rescue Plan (“ARP”) Rural Payments held on its balance sheet as of September 30, 2022, for the potential recognition of additional income. Financial guidance for 2022 does not include the recognition of additional income in the fourth quarter of 2022 beyond the $16.2 million recorded in the nine months ended September 30, 2022. Net income attributable to Acadia stockholders for the third quarter of 2022 was $71.1 million, or $0.78 per diluted share.

View on SEC.gov

Browse all earnings releases →

Acadia Healthcare Company, Inc. filing history →

Source: SEC EDGAR

accession 0001157523-22-001443

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.